Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

被引：0
|
作者：
Dennis Schrijnders
Geertruida H. de Bock
Sebastiaan T. Houweling
Kornelis J. J. van Hateren
Klaas H. Groenier
Jeffrey A. Johnson
Henk J. G. Bilo
Nanne Kleefstra
Gijs W. D. Landman
机构：
[1] Isala,Diabetes Centre
[2] Langerhans Medical Research Group,Department of Epidemiology
[3] University of Groningen,Department of General Practice
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Center Groningen,Department of Internal Medicine
[7] School of Public Health,undefined
[8] University of Alberta,undefined
[9] University of Groningen,undefined
[10] University Medical Center Groningen,undefined
[11] Isala,undefined
[12] Gelre Hospital,undefined
来源：
BMC Cancer | / 17卷
关键词：
Type 2 diabetes; Sulfonylureas; Cancer; Within-class differences;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: A review and meta-analysis
    Nath, Moumita
    Nath, Sayantan
    Choudhury, Yashmin
    META GENE, 2021, 27
  • [42] Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Zhang, Kui
    Bai, Peng
    Dai, Hao
    Deng, Zhenhua
    PRIMARY CARE DIABETES, 2021, 15 (01) : 52 - 58
  • [43] Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study
    Dianatshoar, Diba
    Alidaee, Tara
    Sarhangi, Negar
    Afshari, Mahdi
    Meybodi, Hamid Reza Aghaei
    Hasanzad, Mandana
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 133 - 139
  • [44] Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
    Chen, Yu-Ching
    Kok, Victor C.
    Chien, Ching-Hsuan
    Horng, Jorng-Tzong
    Tsai, Jeffrey J. P.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1315 - 1323
  • [45] Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center Diabetes Database
    Yamamoto-Honda, Ritsuko
    Takahashi, Yoshihiko
    Yoshida, Yoko
    Kwazu, Shoji
    Iwamoto, Yasuhiko
    Kajio, Hiroshi
    Yanai, Hidekatsu
    Mishima, Shuichi
    Shimbo, Takuro
    Noda, Mitsuhiko
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (06) : 908 - 914
  • [46] Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus: A 6-Year Follow-up Study
    Lin, Hsiu-Chen
    Kachingwe, Baxter H.
    Lin, Hsiu-Li
    Cheng, Hui Wen
    Uang, Yow-Shieng
    Wang, Li-Hsuan
    PHARMACOTHERAPY, 2014, 34 (01): : 36 - 45
  • [47] Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai
    Xu, Huilin
    Zhang, Fen
    Xu, Wanghong
    Li, Jun
    Zhu, Jingjing
    Zhang, Minlu
    Wu, Zhenyu
    Qin, Guoyou
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 171
  • [48] Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study
    Diba Dianatshoar
    Tara Alidaee
    Negar Sarhangi
    Mahdi Afshari
    Hamid Reza Aghaei Meybodi
    Mandana Hasanzad
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 133 - 139
  • [49] Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
    Willi Oberaigner
    Christoph Ebenbichler
    Karin Oberaigner
    Martin Juchum
    Hans Robert Schönherr
    Monika Lechleitner
    BMC Public Health, 14
  • [50] Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
    Oberaigner, Willi
    Ebenbichler, Christoph
    Oberaigner, Karin
    Juchum, Martin
    Schoenherr, Hans Robert
    Lechleitner, Monika
    BMC PUBLIC HEALTH, 2014, 14
12345